Pancreatic adenocarcinoma: Clinical practice guidelines in oncology

Margaret A. Tempero; J. Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B. Benson; Jordan D. Berlin; John L. Cameron; Ephraim S. Casper; Steven J. Cohen; Michelle Duff; Joshua D.I. Ellenhorn; William G. Hawkins; John P. Hoffman; Boris W. Kuvshinoff; Mokenge P. Malafa; Peter Muscarella; Eric K. Nakakura; Aaron R. Sasson; Sarah P. Thayer; Douglas S. Tyler; Robert S. Warren; Samuel Whiting; Christopher Willett; Robert A. Wolff

doi:10.6004/jnccn.2010.0073

Pancreatic adenocarcinoma: Clinical practice guidelines in oncology

Margaret A. Tempero, J. Pablo Arnoletti, Stephen Behrman, Edgar Ben-Josef, Al B. Benson, Jordan D. Berlin, John L. Cameron, Ephraim S. Casper, Steven J. Cohen, Michelle Duff, Joshua D.I. Ellenhorn, William G. Hawkins, John P. Hoffman, Boris W. Kuvshinoff, Mokenge P. Malafa, Peter Muscarella, Eric K. Nakakura, Aaron R. Sasson, Sarah P. Thayer, Douglas S. TylerRobert S. Warren, Samuel Whiting, Christopher Willett, Robert A. Wolff

Research output: Contribution to journal › Review article › peer-review

157 Scopus citations

Abstract

Overall, in view of the relatively high likelihood of a poor outcome for patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.

Original language	English (US)
Pages (from-to)	972-973+991-1016
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	8
Issue number	9
DOIs	https://doi.org/10.6004/jnccn.2010.0073
State	Published - Sep 2010
Externally published	Yes

Keywords

Adenocarcinoma
Ductal carcinoma
Endoscopic retrograde cholangiopancreatography
Gemcitabine
NCCN clinical practice guidelines
NCCN guidelines
Pancreas
Ultrasonography

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2010.0073

Cite this

Tempero, M. A., Arnoletti, J. P., Behrman, S., Ben-Josef, E., Benson, A. B., Berlin, J. D., Cameron, J. L., Casper, E. S., Cohen, S. J., Duff, M., Ellenhorn, J. D. I., Hawkins, W. G., Hoffman, J. P., Kuvshinoff, B. W., Malafa, M. P., Muscarella, P., Nakakura, E. K., Sasson, A. R., Thayer, S. P., ... Wolff, R. A. (2010). Pancreatic adenocarcinoma: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 8(9), 972-973+991-1016. https://doi.org/10.6004/jnccn.2010.0073

Tempero, MA, Arnoletti, JP, Behrman, S, Ben-Josef, E, Benson, AB, Berlin, JD, Cameron, JL, Casper, ES, Cohen, SJ, Duff, M, Ellenhorn, JDI, Hawkins, WG, Hoffman, JP, Kuvshinoff, BW, Malafa, MP, Muscarella, P, Nakakura, EK, Sasson, AR, Thayer, SP, Tyler, DS, Warren, RS, Whiting, S, Willett, C & Wolff, RA 2010, 'Pancreatic adenocarcinoma: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 8, no. 9, pp. 972-973+991-1016. https://doi.org/10.6004/jnccn.2010.0073

@article{38ff5e0c9bf44614b7256dde4d1d44d3,

title = "Pancreatic adenocarcinoma: Clinical practice guidelines in oncology",

abstract = "Overall, in view of the relatively high likelihood of a poor outcome for patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.",

keywords = "Adenocarcinoma, Ductal carcinoma, Endoscopic retrograde cholangiopancreatography, Gemcitabine, NCCN clinical practice guidelines, NCCN guidelines, Pancreas, Ultrasonography",

author = "Tempero, {Margaret A.} and Arnoletti, {J. Pablo} and Stephen Behrman and Edgar Ben-Josef and Benson, {Al B.} and Berlin, {Jordan D.} and Cameron, {John L.} and Casper, {Ephraim S.} and Cohen, {Steven J.} and Michelle Duff and Ellenhorn, {Joshua D.I.} and Hawkins, {William G.} and Hoffman, {John P.} and Kuvshinoff, {Boris W.} and Malafa, {Mokenge P.} and Peter Muscarella and Nakakura, {Eric K.} and Sasson, {Aaron R.} and Thayer, {Sarah P.} and Tyler, {Douglas S.} and Warren, {Robert S.} and Samuel Whiting and Christopher Willett and Wolff, {Robert A.}",

year = "2010",

month = sep,

doi = "10.6004/jnccn.2010.0073",

language = "English (US)",

volume = "8",

pages = "972--973+991--1016",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "9",

}

TY - JOUR

T1 - Pancreatic adenocarcinoma

T2 - Clinical practice guidelines in oncology

AU - Tempero, Margaret A.

AU - Arnoletti, J. Pablo

AU - Behrman, Stephen

AU - Ben-Josef, Edgar

AU - Benson, Al B.

AU - Berlin, Jordan D.

AU - Cameron, John L.

AU - Casper, Ephraim S.

AU - Cohen, Steven J.

AU - Duff, Michelle

AU - Ellenhorn, Joshua D.I.

AU - Hawkins, William G.

AU - Hoffman, John P.

AU - Kuvshinoff, Boris W.

AU - Malafa, Mokenge P.

AU - Muscarella, Peter

AU - Nakakura, Eric K.

AU - Sasson, Aaron R.

AU - Thayer, Sarah P.

AU - Tyler, Douglas S.

AU - Warren, Robert S.

AU - Whiting, Samuel

AU - Willett, Christopher

AU - Wolff, Robert A.

PY - 2010/9

Y1 - 2010/9

N2 - Overall, in view of the relatively high likelihood of a poor outcome for patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.

AB - Overall, in view of the relatively high likelihood of a poor outcome for patients with all stages of pancreatic cancer, the panel recommends that investigational options be considered in all phases of disease management. Specific palliative measures are recommended for patients with advanced pancreatic adenocarcinoma characterized by biliary or gastric obstruction, severe abdominal pain, or other tumor-associated manifestations of the disease.

KW - Adenocarcinoma

KW - Ductal carcinoma

KW - Endoscopic retrograde cholangiopancreatography

KW - Gemcitabine

KW - NCCN clinical practice guidelines

KW - NCCN guidelines

KW - Pancreas

KW - Ultrasonography

UR - http://www.scopus.com/inward/record.url?scp=77958155207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958155207&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2010.0073

DO - 10.6004/jnccn.2010.0073

M3 - Review article

C2 - 20876541

AN - SCOPUS:77958155207

SN - 1540-1405

VL - 8

SP - 972-973+991-1016

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 9

ER -

Pancreatic adenocarcinoma: Clinical practice guidelines in oncology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this